HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
April 21, 2003
- Ban on Ethical Drug Advertising Could Be Lifted: PFSB Official
April 21, 2003
- JPA to Undertake Emergency Survey on Sales of OTC Drugs
April 21, 2003
- 1st Generics of More than 10 Active Ingredients Expected
April 21, 2003
- Hac Kimisawa: Consolidated Ordinary Profits Down 8.7%
April 21, 2003
- Korosho to Announce Draft Vision for Medical Care System Reform
April 21, 2003
- KIRINDO: Sales Up 17.6%, Profits Up 128%
April 21, 2003
- 80% of Doctors Predict Fewer Outpatients Due to 30% Copayment: So-net M3 Survey
April 21, 2003
- OTC NEWS IN BRIEF
April 21, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 21, 2003
- NEW PRODUCTS NEWS IN BRIEF
April 21, 2003
- Wyeth Lederle Japan: Profits Grow Remarkably
April 21, 2003
- DIAGNOSTIC NEWS IN BRIEF
April 21, 2003
- Hisamitsu: Consolidated Sales Up 0.7% to \70 Bil.
April 21, 2003
- WORLD NEWS IN BRIEF
April 21, 2003
- Chugai to Be Ranked No. 4 after Integration with Nippon Roche: Mr Nagayama
April 21, 2003
- The 26th General Assembly of the Japan Medical Congress
April 21, 2003
- Makers, Wholesalers Differ on Cost-sharing for Safety Measures on Bio-derived Products
April 21, 2003
- Kaken Researchers Awarded JPSTJ Prize
April 21, 2003
- No Conclusions Reached on Effects of Antioxidants on Cardiovascular Events: JCS Meeting
April 21, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
